XML 63 R49.htm IDEA: XBRL DOCUMENT v3.21.1
Stock Based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement [Abstract]  
Summary of Changes to Issuances under 2017 Equity Plan The table below summarizes changes to the issuances under the Company’s 2017 Equity Plan for the periods indicated, excluding awards granted under the Company’s subsidiary incentive plans that are exchangeable for Tiptree common stock:
2017 Equity Plan
Number of shares (1)
Available for issuance as of December 31, 20203,788,417 
RSU, stock and option awards granted(25,381)
Available for issuance as of March 31, 20213,763,036 
(1)    Excludes awards granted under the Company’s subsidiary incentive plans that are exchangeable for Tiptree common stock.
Summary of Changes to Issuances of RSUs under the 2017 Equity Plan
The following table presents changes to the issuances of RSUs and stock awards under the 2017 Equity Plan for the periods indicated:
Number of shares issuableWeighted average grant date fair value
Unvested units as of December 31, 2020953,145 $6.52 
Granted
25,381 5.03 
Vested(379,514)6.32 
Unvested units as of March 31, 2021599,012 $6.59 
The following tables present the detail of the granted and vested RSUs and stock awards for the periods indicated:
Three Months Ended
March 31,
Three Months Ended
March 31,
Granted20212020Vested20212020
Directors25,381 9,232 Directors25,381 9,232 
Employees (1)
— 469,257 Employees354,133 364,984 
Total Granted25,381 478,489 Total Vested379,514 374,216 
Taxes(34,828)(51,507)
Net Vested344,686 322,709 
(1)    Includes 256,619 shares that vest ratably over three years and 212,638 shares that cliff vest in February 2021 for the three months ended March 31, 2020.
The following table presents the Company's stock option activity for the current period:
Options outstandingWeighted average exercise price (in dollars per stock option)Weighted average grant date value (in dollars per stock option)Options exercisable
Balance, December 31, 20201,715,619 $6.49 $2.29 — 
Balance, March 31, 20211,715,619 $6.49 $2.29 — 
Weighted average remaining contractual term at March 31, 2021 (in years)
6.9
Summary of Changes to Issuances of Subsidiary RSU's under Subsidiary Incentive Plan
The following table presents changes to the issuances of subsidiary awards under the subsidiary incentive plans for the periods indicated:
Grant date fair value of equity shares issuable
Unvested balance as of December 31, 2020$4,305 
Granted1,079 
Vested(1,358)
Unvested balance as of March 31, 2021$4,026 
Schedule of Assumptions Used to Estimate the Fair Values of the Stock Options Granted
The following table presents the assumptions used to estimate the fair values of the stock options granted for the following periods:
Valuation Input (1)
Three Months Ended March 31, 2020
AssumptionAverage
Historical volatility27.60%N/A
Risk-free rate1.51%N/A
Dividend yield2.20%N/A
Expected term (years)7.0
(1) Not applicable for the three months ended March 31, 2021 as there were no new grants during the period.
Schedule of Stock-based Compensation Expense and Related Income Tax Benefit
Stock Based Compensation Expense

The following table presents total stock based compensation expense and the related income tax benefit recognized on the condensed consolidated statements of operations:
Three Months Ended
March 31,
20212020
Employee compensation and benefits$955 $1,543 
Director compensation110 73 
Income tax benefit(224)(349)
Net stock based compensation expense$841 $1,267 
Schedule of Additional Information on Total Non-vested Stock-based Compensation
Additional information on total non-vested stock based compensation is as follows:
As of
March 31, 2021
Stock optionsRestricted stock awards and RSUs
Unrecognized compensation cost related to non-vested awards$434 $4,721 
Weighted - average recognition period (in years)2.071.73